acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I firmly believe that the company has a media plan in place to promote LymPro to all the major media outlets when the time is right.
It's all part of Gerald's master plan.
"Patience is a virtue."
Twitter: @AmarantusBio .... 10,000+ followers.
"The trend is your friend but it's the science that will make you rich."
.30 by Friday if the news is what I expect it to be.
The global media coverage on LymPro will be tremendous.
You're getting MANF and Eltoprazine for free.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. $1.00 by the end of the year?
Don't forget about Cavendish Global which represents $200B in investment capital being a supporter for the #C4CT Summit.
I think your price target are realistic for this year but much too low moving forward.
Interesting days, weeks, months, and years ahead.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
I think your .25 price target gets blown out of the water this week. I wouldn't be surprised to see .30-.35 by Friday.
Have a great weekend!!!
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. Try not being so negative and enjoy the move higher through the up-listing.
"LymPro has completed two Phase 1 clinical studies in over 80 patients, showing 98% sensitivity and 96% specificity for Alzheimer's disease diagnosis."
http://www.fiercemedicaldevices.com/press-releases/amarantus-bioscience-licenses-lympro-alzheimers-disease-diagnostic-blood-te
If these are in-line with the numbers that Gerald will release this week the share price will hit the .40-.50 range. The global media coverage on LymPro will be tremendous.
Stay tuned for news.
"The trend is your friend but it's the science that will make you rich."
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. Buckle up!!!
LOL!!! $AMBS is moving higher because the market is discovering the tremendous value that LymPro and MANF offer.
Neither the Money Running Group, the Easter Bunny, or Santa Claus had anything to do with today's move higher.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. The trend is your friend but it's the science that will make you rich.
.40-.50 by October 1 is very reasonable. Possibly a bit low.
The market is just finding out about LymPro and MANF.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. The trend is your friend but the science can make you a fortune.
Based on today's trading volume and price increase I think .22 - .25 is possible by the Summit.
Interesting week ahead.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
That doesn't mean that Gerald can't comment about progress being made in finalizing the agreement.
Time frames can change.
Buy a few shares before next week's earnings report and conference call.
I expect the share price to hit the .17 range by the Summit.
Depending on what news is released relative to the LymPro data and a partnership announcement I expect the share price will be either at .12 or .22 after the Summit.
Overdue for substantive "MANF" news.
Interesting days ahead.
"Patience is a virtue."
Twitter: @AmarantusBio .... 10,000+ followers.
As you know it only takes one bit of substantial news to blow the 50 day MA to smithereens. Penny stocks are notorious for not following moving averages.
Stating that the pps can't hold at 50% above the 50 day moving average is your opinion. The right news could take it substantially higher than 50%.
Stay tuned for news.
Interesting ten days ahead.
Twitter: @AmarantusBio .... 10,000+ followers.
Having Jim Greenwood as a panelist at "C4CT" is very "significant" news.
It wouldn't surprise me if the share price opens above .15 tomorrow and moves back towards .18 from there.
The word is definitely getting out to the industry and the market that $AMBS is "for real" and has tremendous upside.
LymPro news and a partnership should take the share price to the .25 range and trend up from there to the up-listing.
Interesting weeks and months ahead.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. I can't understand why anyone is selling here and giving away profits.
The truth hurts.
Don't get burned by "Pumpty Dumpty" when the bottom falls out:
http://www.bizjournals.com/southflorida/blog/2012/03/shares-of-pizza-fusion-acquirer-drop.html?page=all
This will be my last post until there is significant news.
Best of luck to everyone. I hope everyone makes a substantial profit on their $AMBS investment.
I expect the next Chairman's blog to be published tomorrow or Friday will address a number of related issues and will probably answer your question.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
Considering the talented management team that Gerald has surrounding him and who are involved in dealing with and deciding such issues as whether or not to release the LymPro data at the A.A.I.C., I have to believe that something monumental is in the offering that made the delay the "right move".
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. Don't regret not adding shares here.
With the right news all will be forgiven.
As Gerald once told me, "I don't get any e-mail or phone calls when the share price is up 20%."
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. Everyone wants a better share price.
I'm willing to give Gerald the benefit of the doubt and assume that he has a "big picture" scenario in which delaying the disclosure of the LymPro data at the A.A.I.C. was the correct decision.
I expect that by the end of July that it will be obvious to the shareholders and the market why he chose the current course of action.
Interesting days and weeks ahead.
Twitter: @AmarantusBio .... 10,000+ followers.
If the sensitivity and specificity numbers are good for LymPro a two week delay is no big deal.
It just moves us two weeks closer to the partnership announcement and it provided us with the opportunity to buy some cheap shares.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. As Gerald once stated he knows more about what is going on within the company than any of the stock board posters.
Most people are intelligent enough to find out that @AmarantusBio has over 10,000 followers on Twitter.
Can't imagine that anyone on this board would be so stupid as to not be able to find this factual information.
Just saying!!!
Nothing has changed.
When it became obvious that the sensitivity and specificity numbers weren't going to be released for two weeks the news provided an opportunity for some profit taking and consolidation especially after the recent move higher in anticipation of news.
I added shares today and will add a few more over the next two weeks leading up to the #C4CT (Coalition for Concussion Treatment) Concussion Awareness Summit, on Thursday, July 31, 2014 at the United Nations in New York City, NY.
Brewer Sports International (BSI) and Cavendish Global have partnered for the summit. The summit will be focused on the emerging hypothesis that brain injury may increase the risk of Alzheimer's disease.
I expect there will be other news to move the share price higher prior to #C4CT.
Don't be on the sidelines when the news is released.
"Patience is a virtue."
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. The sky is not falling.
.40-.50 by October 1 is realistic.
The up-listing will allow the major funds to buy shares.
The penny flippers are getting left behind and the shorts are getting burned badly.
It's one thing to short 100,000 shares at .07. It's much different to short 100,000 shares at .20+.
Major milestones will get hit and catalysts will happen.
"We shall see said the blind man to the deaf mute."
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
He just wishes he was me.
Twitter: @AmarantusBio .... 10,000+ followers.
Global Media's Attention Focus On LymPro.
Will bring 1,000's of new shareholders to $AMBS.
MANF with its orphan indications will bring 1,000's more.
All before the up-listing.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
Tee time at 12:26.
Even bad golfers can own $AMBS shares.
I hold $AMBS shares in margin accounts with both Ameritrade and E-Trade. Neither allows $AMBS shares to be purchased on margin or shorted.
On stocks that I own that I don't want to be available for them to loan to shorts I have to request it in an e-mail.
That is not true.
Both Ameritrade and E-trade require that you call them and request that your shares are not to be loaned to the shorts. Merely placing a limit sell order - AON - GTC - doesn't accomplish what you want it to.
Anyone here can call customer service at either Ameritrade or E-Trade to verify what I've posted.
I think it's somewhat irrelevant with $AMBS as neither allows $AMBS to be shorted. It may be relevant to other stocks you own or when $AMBS up-lists.
Feel free to post your findings.
Twitter: @AmarantusBio .... 10,000+ followers.
Four Rules for $AMBS Before the LymPro Data Is Released
1. If you don't own $AMBS shares buy some. The sooner the better.
2. If you own $AMBS shares add more. You already know it's going much higher.
3. If you are short $AMBS shares cover. Your losses will only increase if you don't.
4. If you are thinking of selling don't. Why join those who have already missed substantial profits.
The LymPro data is only the first of a number of milestones that will continue to move the share price higher through the up-listing.
"Hold for the gold."
Note: This was posted by ambsadvocate on the Yahoo $AMBS board.
I suggest you buy shares at the open tomorrow.
.20 by Friday would not surprise me.
The "word" is getting out to the market.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
Gerald's Twitter session:
http://bionapcfa.blogspot.com/2014/07/askambs-twitter-chat-nice-success-for.html
LOL!!! $1.5M for a potential $500M market in three years.
If there is a cash payment I think it will exceed $25M. Milestone payments could be in the $100M range over the next three years. Royalties will be a separate issue.
Isn't it fun to speculate when it doesn't cost anything.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. A week from today I'll have a more definitive prediction.
I expect there will be an up-front cash payment because the partner wants to demonstrate its strong belief in the success that LymPro will have in the market place.
The higher the up-front cash payment the more credibility it gives to LymPro's potential for success.
The LymPro data will provide a basis to better speculate on how much the cash payment might be.
Interesting week ahead.
Twitter: @AmarantusBio .... 10,000+ followers.
p.s. Add a few shares before the global media discovers LymPro
Gerald's Twitter Chat Session:
http://bionapcfa.blogspot.com/2014/07/askambs-twitter-chat-nice-success-for.html
That's because I do.
Some poster make it a point to state that they own millions of shares. If they are fortunate to own that many shares and want to broadcast it then that is their choice.
It doesn't matter to me if someone owns 10,000 shares or 10,000,000 shares if I think their comments have validity.
I don't know of another stock in the market that has the tremendous upside potential that $AMBS offers in both the short term and the long term.
Exciting days, weeks, and months ahead.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000+ followers.
Anyone holding 500,000 shares is also holding 112,000 shares.
Twitter: @AmarantusBio .... 10,000 followers.
This an example of the type of attention that Twitter can create:
https://twitter.com/SKITHEG/status/487986382816935936/photo/1
Imagine this getting to 1,000,000 potential investors in a matter of minutes.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000 followers.
You under estimate the ability of traders and investors to promote the LymPro news and $AMBS through the social media such as Twitter and how fast a stock can move up on news.
I will be very surprised if the share price isn't above .20 by Friday if the LymPro data is as positive as I expect it to be. There's a big difference between shorting 100,000 shares at .06 versus shorting 100,000 shares at .15 or higher especially when there are other milestones and catalysts that could occur at any time. Gerald did say that the company had six filings for grant funding currently in the pipeline.
Anyone selling here doesn't have a clue about what is about to happen.
Stay tuned for news.
:47-1:03 mark:
I wish I could afford to own millions of shares like you.
Unfortunately I still own the same 112,000 shares now that I owned a year ago.
I think you'll make a lot of money on those shares and I imagine Gerald will introduce you at the first shareholder's meeting after the up-listing. Possibly a photo op for you.
Exciting times ahead for the major shareholders such as yourself. Don't forget that the small shareholders are the ones that move the share price higher.
Looking forward to the LymPro data next week. The share price could be above .20 by next Friday.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000 followers.
p.s. I wish I had your skill for picking stocks. I can only hope to achieve your acumen in doing so.
.40-.50 range by October 1 seems reasonable with the milestones hit and the up-listing announced.
The higher the share price climbs the ability of the shorts and penny flippers to impact it diminishes especially when the news is bringing first time buyers to $AMBS.
If you've ever seen a wild fire generate a "fire storm" then you can appreciate that a stock can generate its own upward momentum.
I think that is about to happen with $AMBS.
Next weeks should launch it upwards.
Twitter: @AmarantusBio .... 10,000 followers.